PHARMATHENE, INC
Biotechnology research, development and manufacturing. Biodefense vaccines/therapeutics
Filings counts every document on the register, amendments included. Income is the fees reported to clients, counting the current version of each report once.
Income by year
Filings
| Filing | Client | Income | Expenses |
|---|---|---|---|
|
3rd Quarter - Amendment 3rd Quarter 2011
|
PHARMATHENE, INC | — income | $224,325 expenses |
|
2nd Quarter - Amendment 2nd Quarter 2011
|
PHARMATHENE, INC | — income | $289,770 expenses |
|
4th Quarter - Report 4th Quarter 2011
|
PHARMATHENE, INC | — income | $211,875 expenses |
|
3rd Quarter - Reportreplaced 3rd Quarter 2011
|
PHARMATHENE, INC | — income | $299,325 expenses |
|
2nd Quarter - Reportreplaced 2nd Quarter 2011
|
PHARMATHENE, INC | — income | $314,770 expenses |
|
1st Quarter - Report 1st Quarter 2011
|
PHARMATHENE, INC | — income | $137,033 expenses |
Clients
Everyone this filer has reported for, with the reports filed and the income they disclose.
| Client | Reports | Income |
|---|---|---|
| PHARMATHENE, INC | 33 | — |
Lobbyists
Everyone named on this filer's reports, with the government post they most recently disclosed here.
| Lobbyist | Covered position, as disclosed |
|---|---|
| FRANCESCA COOK | Sr. VP Policy and government Affairs |
| MARK EDWARD COOKE | Sr. Director Government Affairs |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
From reports filed under the Lobbying Disclosure Act. A firm reports income from each client; an organisation lobbying for itself reports its own expenses instead. Each figure links to the filing it comes from.